SEC Form 4 research
| Issuer | Mirum Pharmaceuticals, Inc. |
|---|---|
| Tickers | MIRM |
| Reporting owners | 51 |
| Officers and directors | 15 |
| Last public filing | 2026-10-14 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-14 | 2026-10-09 | Myers Robert Paul | A | 25,000 | $0 | Not reported |
| 2026-10-14 | 2026-10-09 | Myers Robert Paul | A | 40,000 | $0 | Not reported |
| 2026-09-15 | 2026-09-14 | BJERKHOLT ERIC | S | 9,943 | $98.37 | Not reported |
| 2026-09-03 | 2026-09-02 | Howe Jolanda | S | 658 | $100 | Not reported |
| 2026-09-03 | 2026-09-01 | Peetz Christopher | S | 21,688 | $98.91 | Not reported |
| 2026-09-03 | 2026-09-01 | Peetz Christopher | S | 8,312 | $98.08 | Not reported |
| 2026-08-19 | 2026-08-18 | Howe Jolanda | S | 40,000 | $100 | Not reported |
| 2026-08-12 | 2026-08-11 | BJERKHOLT ERIC | S | 6,001 | $99.9 | Not reported |
| 2026-08-11 | 2026-08-10 | Peetz Christopher | S | 2,300 | $100.14 | Not reported |
| 2026-08-11 | 2026-08-10 | Peetz Christopher | S | 6,017 | $99.25 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.